A Clinical Study of the TSX Dental Implant System (Xpresso)
ConditionTooth Loss
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorZimVie
About this trial
A prospective, observational, multicenter study where 62 patients needing implants in the maxilla or mandible will be enrolled. The patients will be restored with a final prosthesis no later than 4 months following implant placement surgery. The patients will come back for follow-up evaluations yearly for 2 years.
Eligibility criteria
Qualifiers
Patients at least 18 years of age
Patients for whom a decision has already been made to use a dental implant in an edentulous or immediately removed tooth site to be fully restored in the mandible or maxilla.
Site planned for immediate extraction and immediate restoration should have intact bony walls- Type I (as described in Special Procedures section) sockets as verified by CBCT and during surgery; Type II may be considered at the discretion of the treating clinician
Previously extracted sites (healed at least 3-4 months)
Disqualifiers
Patients with known systemic diseases such as diabetes, endocrine disease, heart disease, immuno-compromised, or mental disorders that are uncontrolled at the time of enrollment.
Patients with current use of bisphosphonates.
Patients with active infection or severe inflammation in the areas intended for treatment.
Patients with more than10 cigarette per day smoking habit.
Trial design
Treatments tested in this trial
- TSX
Treatment groups
62 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov